Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 5c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q2 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
• Euroseas Ltd. (ESEA) Tops Q2 EPS by 61c
• Madison Square Garden Sports Corp. (MSGS) Tops Q4 EPS by 62c